Press release
17.01.2025 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025 download […]
Important notification
09.01.2025 To the attention of interested persons The European Commission posted two public consultation for economic operators (manufacturers, authorised representatives, […]
Important notification
23.12.2024 To the attention of interested persons Considering the approval of Order of the Minister of Health no. 5930 of […]
Important notification
17.12.2024 To the attention of interested persons The European Commission launched on its website (https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/14155-EU-rules-on-medical-devices-and-in-vitro-diagnostics-targeted-evaluation_en) a request for participation in […]
Press release
13.12.2024 To the attention of interested persons Alofisel withdrawn from the EU market download document …
Press release
09.12.2024 To the attention of interested persons ETF statement on the loss of activity of anti-spike protein monoclonal antibodies due […]
Press release
29.11.2024 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2024 download […]
Press release
15.11.2024 To the attention of interested persons Updated advice to minimise risks of interaction between weight loss medicine Mysimba and […]
Press release
14.11.2024 To the attention of interested persons Leqembi recommended for treatment of early Alzheimer’s disease download document …
Important notification
12.11.2024 To the attention of economic operators approved by the National Agency for Medicines and Medical Devices of Romania who […]